Paul G. Gillease

Part of Compagnie de Saint-Gobain SA, Chemfab Corp. is an emerging biotechnology company based in Merrimack, NH that aims to accelerate patient access to transformational immunotherapies, addressing several of the most challenging unmet medical needs in cancer. The company focuses on natural killer (NK) cell biology and is leveraging multiple advanced patented technologies, including an induced pluripotent stem cell (iPSC) platform for chimeric antigen receptors (CAR) NK cell therapy, next-generation precision gene-editing to enhance targeting of NK cells, and NK engager multi-functional antibodies. The company's initial product portfolio focuses on both hematological malignancies such as multiple myeloma and solid tumors including hepatocellular carcinoma (HCC) and glioblastoma. HCC is a leading cause of cancer-related death, expected to cause 1 million deaths annually by 2030. Despite advances in immunotherapy, with current treatment options including multi-kinase inhibitors (TKI) and checkpoint inhibitors, life expectancy for patients diagnosed with HCC remains very low.

American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC.

The Society of Plastics Engineers is a global organization with over 22,500 members in 84 countries. The non-profit company is based in Danbury, CT and has subsidiaries in France. The company's mission is to unite plastics professionals worldwide and help them succeed by providing networking opportunities, events, training, and knowledge sharing. The CEO of the company is Patrick Farrey.

Euro Concepts Ltd. is a private company that retails tiles. The company is based in New York, NY.

LRM Industries International, Inc. manufactures fiber-reinforced structural thermoplastic parts. The company is headquartered in West Melbourne, FL.

Xemex Holdings Corporation is a diversified private investment company with a primary focus on opportunistic commercial real estate ventures. Founded in 2007, the firm employs a disciplined, multi-faceted approach to generating outsized risk-adjusted returns. Its team of experienced professionals possesses advanced capabilities across a wealth of industries and exhibits a rich history of both entrepreneurial & institutional accomplishments. Coupled with extensive business relationships and substantial financial resources, Xemex is equipped to quickly & prudently identify, evaluate, close, and execute complex investments, from the repositioning and redevelopment of mixed-use urban properties to the commercialization of fledgling technologies. Consistent with its name, which is derived from the Greek word Xemosis, meaning optimal mixture, Xemex's burgeoning investment portfolio encompasses the optimal mixture of real estate products, primarily commercial real estate development projects, and investments in media and entertainment, consumer products, bridge financing, and the purchase and workout of sub-prime mortgages. Led by a diverse group of professionals with a proven track record of value enhancement via the acquisition, redevelopment and management of real estate projects, Xemex invests opportunistically in real estate assets situated predominantly in the New York City area. Additionally, Xemex invests a small percentage of its capital in startup or high growth enterprises that possess stellar management and deployable business plans. Through its stake in these companies, Xemex utilizes its substantial managerial and financial resources to strengthen these entities and maximize their value.

Stem Capital Partners Ltd is a private equity firm founded in 2013. The firm headquartered in Hong Kong.

SPL Associates is a private company based in Brooklyn, NY.